Have you ever wondered how developers turn innovative AI concepts into fully functional, scalable applications? Imagine crafting an app powered by generative AI, one that adapts intelligently to user ...

For fixing Windows errors, we recommend Fortect: Fortect will identify and deploy the correct fix for your Windows errors. Follow the 3 easy steps to get rid of Windows errors: Follow these steps to ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Tennessee is preparing to execute a woman for the first time in more than two centuries, after the state’s Supreme Court set the execution date for Christa Gail Pike, the only woman on Tennessee’s ...

If Christa Gail Pike's execution proceeds as planned next year, she will become the first woman put to death in Tennessee since the state began to formally document capital punishment more than a ...

The Pentagon’s current management of operations is leading it toward strategic insolvency and increasing risks to warfighters in the event of great-power war. A slow but steady accumulation of mission ...

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally circa 2010. If he was forced to pick a favorite ...

Oasis Security has uncovered a flaw in the widely used AI-powered code editor Cursor that lets malicious repositories silently execute code the moment a developer opens them. According to a disclosure ...

A newly disclosed flaw in the Cursor extension allows repositories to automatically execute code when a folder is opened, even without a developer’s consent. The issue stems from the extension’s ...

U.S. Rep. Chip Roy, R-Texas, announced Thursday that he is running to become the next Texas Attorney General. Roy, who represents Texas' 21st Congressional District in the U.S. House, made the ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...

Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...